CHANCELLOR MICHAEL B (Chief Medical Officer) received a stock award from LIPELLA PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/15/2024ACC: 0001753926-24-000539
DirectorOfficer10% Owner· Chief Medical Officer
Since Dec 2022
+144.91K
Net shares
Net buyer
$100.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
144.91K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+144.91K
Price / share
$0.69
Trade value
$100K
% of position
19.8%
3/13/2024
732.73K→877.64K
Total
Net shares
+144.91K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2024 | A · Award | +144.91K | $0.69 | $100K | 19.8% | 732.73K | 877.64K |
| Total | +144.91K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported